Biology of Incretins: GLP 1 and GIP Gastroenterology Full article: Oral glucagon like peptide 1 receptor agonists and combinations of entero pancreatic hormones as treatments for adults with type 2 diabetes: where are we now? What is the pipeline for future medications for obesity? International Journal of Obesity Glucagon like peptide 1 (GLP 1) receptor agonists are incretin analogues that promote glucose mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP 1 receptor agonists and GLP 1 and glucose dependent insulinotropic Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination